T. Rowe Price Health Care ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.44
資產淨值: 34.81
成立日期: 11/06/2025
 
分析
市值分佈:
75.75%
大市值
8.30%
中市值
9.78%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:06) 總持有投資項目: 114  
0%
 
100%
     10大 (35.67%)
代號 名稱 佔比% ▼ 持有日期
COOCooper Companies (The)0.3530/09/2026
ELVElevance Health0.3430/09/2026
CBIOCrescent Biopharma Inc0.3331/10/2026
LEGNLegend Biotech Corp0.3331/10/2026
SLDBSolid Biosciences0.3331/10/2026
MAZEMaze Therapeutics Inc0.3131/10/2026
AKTSAktis Oncology Inc0.3031/10/2026
STOKStoke Therapeutics0.3030/09/2026
AVLNAvalyn Pharma Inc0.3031/10/2026
TNGXTango Therapeutics0.2931/10/2026
CNTA--0.2730/05/2026
CADLCandel Therapeutics0.2731/10/2026
DNTHDianthus Therapeutics0.2530/09/2026
BRVEBraveheart Bio Inc.0.2531/10/2026
MPLTMapLight Therapeutics Inc.0.2331/10/2026
WGSGeneDx Holdings Corp0.2231/07/2026
TECXTectonic Therapeutic Inc.0.2131/10/2026
ROIVRoivant Sciences Ltd0.2131/10/2026
BDTXBlack Diamond Therapeutics0.2131/10/2026
NBIXNeurocrine Biosciences0.2131/10/2026
  1    2    3   4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.